Basilea Pharmaceutica AG (OTCMKTS:BPMUF - Get Free Report)'s share price hit a new 52-week low during mid-day trading on Tuesday . The stock traded as low as $47.50 and last traded at $47.50, with a volume of 10 shares trading hands. The stock had previously closed at $51.00.
Basilea Pharmaceutica Stock Performance
The stock's fifty day moving average is $52.69 and its two-hundred day moving average is $52.75. The company has a quick ratio of 3.27, a current ratio of 4.10 and a debt-to-equity ratio of 5.70.
About Basilea Pharmaceutica
(
Get Free Report)
Basilea Pharmaceutica AG, a commercial-stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. The company offers Cresemba, an intravenous and antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, and the European Union.
Featured Articles
Before you consider Basilea Pharmaceutica, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Basilea Pharmaceutica wasn't on the list.
While Basilea Pharmaceutica currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
